SuperGen to Present at UBS Global Life Sciences Conference on September 25, 2008
SuperGen's presentation at the UBS Global Life Sciences Conference isscheduled to begin at 12:30 p.m. EDT (9:30 a.m. PDT). A live webcast of thepresentation will be available on the investor relations section of theCompany's Web site at http://www.supergen.com. A webcast replay of thepresentation will be available shortly following the live event.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery and development of novel cancer therapies. SuperGenis developing a number of therapeutic anticancer products focused on kinaseand cell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit http://www.supergen.com.Contacts: SuperGen, Inc. Dorland Global Public Relations Timothy L. Enns Michael Beckerich (Media) SVP, Corporate Communications Tel: (212) 677-7632 & Business Development email@example.com Tel: (925) 560-0100 Email: firstname.lastname@example.org Mary M. Vegh Manager, Investor Relations Tel: (925) 560-2845 E-mail: email@example.com
SOURCE SuperGen, Inc.
You May Also Like